Find Academic Supervisors

Harris H. WangView profile

Associate Professor

• Systems Biology
• Synthetic Biology
• Genome Engineering
• +17 more

Harris H. Wang is an Associate Professor in the Department of Systems Biology and Department of Pathology and Cell Biology at Columbia University's Vagelos College of Physicians and Surgeons, where he also serves as Interim Chair of Systems Biology. He is affiliated with the Center for Computational Biology and Bioinformatics (C2B2) and the Integrated Program in Cellular, Molecular and Biomedical Studies (CMBS). B.S., Physics and Mathematics, MIT Ph.D., Biophysics, Harvard University Dr. Wang's research lies at the intersection of systems and synthetic biology, focusing on developing foundational technologies for genome engineering, microbiome manipulation, and synthetic genomics. His lab pioneers methods such as MAGE, MAGIC, CAST, and CAMII to enable high-throughput genetic manipulation, in situ microbiome engineering, and AI-driven microbial culturomics. Key research themes include understanding microbial community dynamics, engineering cellular memory systems, designing biocontained genetic circuits, and applying synthetic biology to human health challenges in personalized medicine and infectious disease. His recent publications reveal a strong trend in spatial and functional metagenomics, CRISPR-based microbiome editing, and synthetic biology tools for data storage and genetic stability. The articles span high-impact journals like Nature , Science , and Nature Biotechnology , reflecting his leadership in developing scalable, programmable biological systems. Scientific Awards: NIH Director’s Early Independence Award Forbes 30 Under 30 in Science Sloan Research Fellowship NSF CAREER Award ONR Young Investigator Award Burroughs Wellcome Fund PATH Award Schaefer Scholar Blavatnik National Award Vilcek Prize PECASE Dr. Wang has advised numerous PhD and postdoctoral researchers, many of whom have gone on to independent scientific careers. His lab is supported by major grants from NIH, NSF, DARPA, DOE, and foundations including the Bill & Melinda Gates Foundation and CZ Biohub NY. He is actively involved in educational initiatives, including organizing Columbia’s iGEM team and the Cold Spring Harbor Laboratory Synthetic Biology course. The Wang Lab is based at the Columbia University Irving Medical Center and is part of national consortia such as the Engineering Biology Research Consortium (EBRC) and the Genome Project-Write (GP-Write) initiative. The lab develops and applies cutting-edge technologies in automation, machine learning, and synthetic biology to engineer microbiomes for applications in medicine, global health, and climate change.

Kaya de BarbaroView profile

Associate Professor

• Developmental Psychology
• Clinical Psychology
• Social Interactions
• +5 more

Dr. Kaya de Barbaro is an Associate Professor in the Department of Psychology at the University of Texas at Austin (College of Liberal Arts). She holds a Ph.D. from the University of California San Diego. Her research focuses on bridging computer science and developmental/clinical psychology, particularly maternal mental health and infant social-emotional development. She directs the Daily Activity Lab, which uses mobile/wearable sensors and machine learning to analyze real-world interactions, aiming to develop just-in-time interventions for new mothers. Key research areas include maternal-infant dynamics, physiological synchronization, and the impact of environmental chaos on development. She has pioneered methods for analyzing high-density data, such as Granger causality and machine learning algorithms to detect behaviors like crying and holding. Recent work emphasizes leveraging ecological momentary assessment surveys and 24-hour LENA audio recordings to understand proximal mechanisms of development. Dr. de Barbaro teaches Psychology 333D (Introduction to Developmental Psychology) and has developed curricula for both in-person and online formats. She is actively involved in training students through the Eureka program at UT Austin. Her lab collaborates on tools like chatbots for postpartum mental health and has published extensively on sensor-based methodologies in developmental science.

Maria CraigView profile

Professor

• Childhood Diabetes
• Type 1 Diabetes
• Virology and Diabetes
• +4 more

Professor Maria Craig is a distinguished academic and researcher at the University of New South Wales, Faculty of Medicine & Health, specializing in childhood diabetes research. She holds a prominent position as a Professor with extensive contributions to the field of pediatric endocrinology and diabetes, particularly focusing on type 1 diabetes in children. Professor Craig's educational background includes: MB BS from the University of Melbourne MMedSc(ClinEpid) from the University of Newcastle PhD from the University of Sydney FRACP (Fellow of the Royal Australasian College of Physicians) Professor Craig's research primarily focuses on childhood diabetes, with special emphasis on prediction and prevention of type 1 diabetes. She has a significant interest in the association between viruses and type 1 diabetes, collaborating with the Virology Research Group at Prince of Wales Hospital (POWH). Together with Professor Bill Rawlinson, she leads the viral theme for the multicentre ENDIA study (endia.org.au). As principal investigator for the CoRD trial, she is conducting a world-first phase 1 study using autologous cord blood for prevention of type 1 diabetes in children with islet autoimmunity. Additionally, she serves as principal investigator for the Australasian Diabetes Data Network (ADDN). Her research portfolio also encompasses the epidemiology of various forms of childhood diabetes (type 1, type 2, cystic fibrosis related diabetes and monogenic diabetes) and diabetes complications, in collaboration with Professor Kim Donaghue at the Children's Hospital at Westmead. Professor Craig's extensive publication record, including over 361 journal articles, demonstrates her leadership in advancing our understanding of childhood diabetes. Her recent work shows increasing focus on early detection methods, risk prediction models, technological interventions for diabetes management, and the complex interplay between viral infections and autoimmune diabetes development. She has been instrumental in developing clinical practice guidelines through her role as co-editor of the International Society for Pediatric and Adolescent Diabetes (ISPAD) guidelines. Professor Craig has received numerous prestigious awards recognizing her contributions to pediatric endocrinology and diabetes research: Australian Paediatric Endocrine Group Young Investigator's Award (1997) Asia Pacific Paediatric Endocrine Society Clinical Teaching Award (2008) Lifetime Honorary Member, Caring and Living as Neighbours (2013) Australian Diabetes Society Jeff Flack Diabetes Data Award (2019) Australian Paediatric Endocrine Group Norman Wettenhall Award for Research and Innovation (2019) Throughout her career, Professor Craig has demonstrated exceptional leadership in professional societies, having served as former president/treasurer of the Australasian Paediatric Endocrine Group (APEG) and currently as Scientific Convenor of the Asia Pacific Paediatric Endocrine Society Fellows school. Her work with the ENDIA study and Australasian Diabetes Data Network represents significant collaborative research efforts involving multiple institutions across Australia and internationally. Her principal investigator roles for major studies indicate substantial research funding support. Professor Craig leads several important research initiatives including the ENDIA study, the CoRD trial, and the Australasian Diabetes Data Network. These programs involve multidisciplinary teams of researchers, clinicians, and support staff working collaboratively to advance understanding and treatment of childhood diabetes. Her work at the intersection of virology and diabetes represents a unique and innovative approach to understanding the environmental triggers of type 1 diabetes.

• Environmental Health Engineering
• Wastewater-Based Epidemiology
• Bioremediation
• +7 more

Rolf Halden is a Professor and Center Director at Arizona State University, holding appointments in the School of Sustainable Engineering and the Built Environment, the Biodesign Center for Environmental Health Engineering, and the Global Futures Scientists and Scholars program. He is a leading expert in environmental health engineering, wastewater-based epidemiology, and bioremediation. Education: Ph.D. in Civil (Environmental) Engineering, University of Minnesota (1997) M.S. in Civil (Environmental) Engineering, University of Minnesota (1994) M.S. in Biology, Technical University of Braunschweig, Germany (1992) Postdoctoral Fellow, Environmental Science, Lawrence Livermore National Laboratory (1998) Research Focus: Halden’s research integrates environmental chemistry, public health, and sustainability to understand how anthropogenic chemicals affect ecological and human health. His lab uses advanced mass spectrometry (LC-MS/MS, MALDI-TOF) to track pollutants such as PPCPs, microplastics, pesticides, and dioxins across air, water, soil, and biological systems. He pioneered the use of wastewater treatment plants as public health observatories, enabling real-time tracking of disease, drug use, and environmental exposures. Scientific Awards & Recognition: Leadership Award, Arizona State University (2018) Rocky Mountain Emmy Award (2018) Leroy E. Burney Lecturer, Johns Hopkins School of Public Health (2011) ACS Expert Program Member (2014–present) NIEHS Superfund R01 Working Group National Leader (2012–2014) Labs & Teams: Halden is the Founding Director of the Biodesign Center for Environmental Health Engineering at ASU, where he leads a multidisciplinary team focused on environmental proteomics, bioremediation, and diagnostic tool development. He also co-leads the Human Health Observatory , a national wastewater monitoring network. Grants & Funding: Halden has secured major funding from NSF, NIH, EPA, DoD, and private industry. Notable projects include the development of in-situ groundwater monitoring devices, national wastewater surveillance of SARS-CoV-2, and studies on microplastics and neurodegenerative disease.

Elena AgapieView profile

Assistant Professor

• Human-Computer Interaction
• Health Informatics
• Behavior Change
• +7 more

Elena Agapie is an Assistant Professor in the Department of Informatics at the Donald Bren School of Information & Computer Sciences, University of California, Irvine. Her research lies at the intersection of human-computer interaction (HCI), health, and behavior change, focusing on designing technologies that support individuals in adopting and maintaining healthy behaviors through human-centered approaches. She is affiliated with the Connected Learning Lab and the Institute for Future Health at UCI. Her educational background includes a PhD in Human Centered Design and Engineering from the University of Washington, an MS in Computer Science from Harvard University, and a BS in Computer Science from Jacobs University Bremen in Germany. She has also conducted research at Microsoft Research, FXPAL, Intel Labs, and NASA Jet Propulsion Lab. Elena's research focuses on designing tools that integrate evidence-based behavioral interventions with user needs, particularly in mental health, chronic disease management, and social support systems. She explores how technology can support therapist-client collaboration, enable tailored health interventions, and leverage crowd expertise for personalized behavior change plans. Her work often involves participatory design, qualitative studies, and prototyping of interactive systems for diverse populations, including youth, hospitalized patients, and underserved communities. Her recent publications, primarily in top-tier venues like CHI and CSCW, reflect a strong trend toward social computing in health, longitudinal behavior support, and the design of inclusive digital health tools. Key themes include goal setting, conversational agents, social sharing in health tracking, and cross-disciplinary collaboration in health technology development. Best Paper Award (top 1%) at CHI 2017 Honorable Mention Best Paper Award (top 5%) at CHI 2016 Best Paper Award (top 1%) at HCOMP 2015 Honorable Mention Best Paper Award (top 5%) at CHI 2013 Elena has been funded by the National Science Foundation, National Institutes of Health, and UCI internal grants. She actively mentors PhD students including Bruna Oewel, Meeshu Agnihotri, and Mehreen Masood, and is currently recruiting students interested in HCI, health, and behavior change. She previously led the outreach program in the HCDE department at the University of Washington, creating workshops that introduced K–12 students to engineering and human-centered design, reaching over 2,000 students across public schools and community events. She runs initiatives to broaden participation in computing and advises undergraduate students in outreach and curriculum development. Her lab collaborates with clinical partners and interdisciplinary teams to ensure real-world impact of her research.

David EricksonView profile

Professor

• Global Health Technology
• Medical Diagnostics
• Microfluidics
• +5 more

David Erickson is the SC Thomas Sze Director and Sibley College Professor at Cornell University's Sibley School of Mechanical and Aerospace Engineering. He also holds a joint professorship in the Division of Nutritional Sciences. His research focuses on global health technologies, medical diagnostics, microfluidics, photonics, nanotechnology, and energy systems. He previously served as Associate Dean of Engineering for Research and Graduate Programs. Erickson leads the NIH-funded PORTENT Center for Point-of-Care Technologies in Global Health and has co-founded companies like Dimensional Energy and VitaScan to commercialize diagnostic and energy technologies. Education: B.Sc., Mechanical Engineering, University of Alberta (1999) M.A.Sc., Mechanical Engineering, University of Toronto (2001) Ph.D., Mechanical Engineering, University of Toronto (2004) Postdoctoral Scholar, Electrical Engineering, California Institute of Technology (2005) Research Interests: Erickson’s work spans global health diagnostics , nanobio applications , and clean energy innovation . He develops portable medical devices for low-resource settings, including smartphone-integrated diagnostic tools for malaria, iron deficiency, and cancer. His lab also pioneers photothermal reactors for CO2 conversion into sustainable fuels. Key areas include: Point-of-care testing for infectious diseases and nutritional deficiencies Nanofluidic and optofluidic technologies for biomolecular analysis Solar-driven energy systems for carbon-neutral fuels Awards: Presidential Early Career Award for Scientists and Engineers (2011) Fellowships from the Optical Society, ASME, and Canadian Academy of Engineering Carbon X-Prize Finalist (2019) for Dimensional Energy’s CO2-to-fuel technology Grants & Industry Collaboration: Erickson’s research is funded by NIH, NSF, ARPA-E, DOE, and USAID. His lab’s innovations have spun off start-ups addressing global health and energy challenges. Notable projects include: - Portable cancer diagnostics in sub-Saharan Africa using mobile phone-based systems - Solar-powered CO2 conversion reactors tested in Wyoming and Arizona Labs & Teams: The Erickson Lab collaborates with the Cornell Atkinson Center for Sustainability and the McGovern Center for Entrepreneurship. Key initiatives include the PORTENT Center and the Dimensional Energy CO2-to-fuel project.

Weiqiang ChenView profile

Professor

• Lab-on-a-Chip
• Organ-on-Chip
• Biomaterials
• +7 more

Weiqiang Chen is a Professor of Mechanical and Biomedical Engineering at New York University's Tandon School of Engineering and Director of Research and PhD Programs. He holds a joint appointment at NYU Langone's Perlmutter Cancer Center as a Faculty Member of the Tumor Immunology Research Program. B.S. in Physics (Nanjing University, 2005) M.S. in Electrical Engineering (Shanghai Jiao Tong University, 2008) M.S. in Electrical and Computer Engineering (Purdue University, 2009) Ph.D. in Mechanical Engineering (University of Michigan, 2014) His research focuses on Lab-on-a-Chip , Organ-on-Chip systems, Biomaterials , and Mechanobiology , with applications in cancer biology, stem cell engineering, and immune monitoring. He pioneers microfabrication technologies for real-time observation of cellular interactions, including CAR T-cell immunotherapy efficacy and tumor microenvironment dynamics. Recent grants include NSF funding for leukemia bone marrow niche modeling, NIH Trailblazer Awards for glioblastoma immunotherapy research, and collaborations with the Arthritis Foundation for synovium-on-chip rheumatoid arthritis studies. His work has been supported by over $2M in federal and institutional research funding. National Science Foundation (NSF) grants for leukemia-on-chip and glioblastoma modeling National Institutes of Health (NIH) awards for immunotherapy research American Heart Association fellowships and institutional training programs Chen's scientific awards include the American Heart Association Fellow distinction, multiple Young Investigator Awards from Lab on a Chip and Biomedical Engineering Society, and recognition for his dissertation on nanotopography in stem cell differentiation. He leads the Applied Micro-Bioengineering Laboratory (AMBL) , which develops microphysiological systems for drug testing and personalized medicine. His team has created the first immunocompetent leukemia-on-a-chip for CAR T-cell therapy screening and glioblastoma models that enable patient-specific immunotherapy validation.

• Child Psychiatry
• Psychiatric Genetics
• Mental Health
• +3 more

Brian Greenfield, MD, FRCPC, ABPN is an Associate Investigator at the Research Institute of the McGill University Health Centre (RI-MUHC) and affiliated with the Brain Repair and Integrative Neuroscience (BRaIN) Program. He is a professor at McGill University and focuses on childhood suicide research through genetic predisposition, disease pathways, treatments, and predictive testing. His work intersects with mental health, borderline personality disorder (BPD), and externalizing disorders in youth. Email: brian.greenfield@muhc.mcgill.ca Dr. Greenfield's research explores the genetic and clinical dimensions of suicide risk in children and adolescents. He investigates biomarkers, predictive algorithms, and treatment models to address mental health crises, particularly in borderline personality disorder and suicidal behaviors. His publications highlight innovative approaches to suicide prevention in youth, including outpatient rapid-response systems, diagnostic tools for BPD, and population-level surveillance algorithms. Research keywords include psychiatry, genetics, health economics, and clinical psychology. As part of the BRaIN Program at RI-MUHC, Dr. Greenfield contributes to translational neuroscience and integrative mental health studies, bridging clinical practice with research to improve outcomes for vulnerable young populations.

James FogartyView profile

Professor

• Human-Computer Interaction
• Ubiquitous Computing
• Accessibility
• +3 more

James Fogarty is a Professor at the Paul G. Allen School of Computer Science & Engineering, University of Washington. He serves as a core member of the DUB Group (Design. Use. Build.), a cross-campus initiative advancing Human-Computer Interaction and Design research. His work bridges computer science with healthcare applications, focusing on ubiquitous computing and accessibility. Fogarty's research centers on Human-Computer Interaction, Ubiquitous Computing, and Accessibility. He develops systems to overcome human obstacles in adopting intelligent computing technologies, particularly in healthcare contexts. His work spans food and symptom tracking for conditions like Irritable Bowel Syndrome, accessibility solutions for mobile interfaces, and self-experimentation frameworks for personalized health. Key themes include designing for real-world adoption, balancing automation with user control in personal informatics, and creating accessible technologies for diverse populations. His most recent publications reveal strong trends in health-focused HCI: 60% address chronic condition management (IBS, migraines), 30% focus on accessibility innovations, and 10% explore collaborative computing. Subfield analysis shows deep specialization in food/symptom tracking systems, mobile accessibility enhancements, and personalized health experimentation frameworks, with consistent emphasis on user-centered design and real-world deployment. Fogarty actively mentors doctoral students including Shaan Chopra, Tae Jones, and Aaleyah Lewis. His research receives direct funding from the National Science Foundation, National Library of Medicine, and Agency for Healthcare Research and Quality, with additional support from Adobe, Google, Intel, Microsoft, and Nokia. His lab operates at the intersection of HCI, health informatics, and ubiquitous computing. He leads projects within the DUB Group ecosystem, focusing on practical applications of sensing technologies and intelligent systems. Current work emphasizes patient-provider collaboration tools, accessibility repair mechanisms for mobile applications, and self-experimentation frameworks for personalized health management.

Ying XuView profile

Assistant Professor

• Early Education
• Evidence-Based Intervention
• Families and Community
• +5 more

Ying Xu is an Assistant Professor at the Harvard Graduate School of Education (HGSE), specializing in the design of AI technologies to support children's language, literacy, STEM learning, and well-being. Her research emphasizes creating AI systems that act as interactive learning companions and language partners for children while fostering human-AI collaboration with educators and families. She holds a Ph.D. in Language, Literacy, and Technology from the University of California, Irvine, and previously served as an Assistant Professor at the University of Michigan from 2022 to 2024. Her work focuses on understanding how AI can complement human interactions, particularly through conversational agents integrated into media like books and educational TV programs. Collaborations include partnerships with PBS KIDS, GBH Education, and Sesame Workshop. Funded by organizations such as the National Science Foundation and Schmidt Futures, her research bridges developmental psychology, education, and human-computer interaction. Xu's studies highlight AI's potential for personalized learning while addressing ethical considerations like AI literacy and social impact. Key achievements include numerous best paper awards and recognition as an Early Career Interdisciplinary Scholar by SRCD. Her interdisciplinary approach involves designing technologies that reflect community values and linguistic/cultural diversity, ensuring equitable access to AI-driven educational tools. Xu advocates for balanced AI integration in children's lives, emphasizing the need for transparency about AI's limitations and the importance of maintaining human connections. She explores how AI can empower stakeholders (e.g., educators, parents) to co-create technologies tailored to their needs, ensuring AI serves as a complement—not replacement—for human interaction. Current projects investigate conversational AI's design principles, children's perceptions of AI, and strategies for fostering critical evaluation of AI-generated content. She also examines how AI affects social interactions and developmental processes, advocating for ethical guidelines to maximize benefits while mitigating risks.

John A. Copland, IIIView profile

Professor

• Cancer Biology
• Molecular Carcinogenesis
• Translational Research
• +3 more

Dr. John A. Copland III is a Professor of Cancer Biology and Biochemistry & Molecular Biology at Mayo Clinic in Jacksonville, Florida. He leads the Cancer Biology and Translational Research Laboratory, focusing on molecular mechanisms of carcinogenesis, tumor progression, and development of targeted cancer therapies. Education: PhD in Physiology & Endocrinology (Medical College of Georgia), MS in Endocrinology (Medical College of Georgia), BS in Chemistry (Columbus College), with postdoctoral training at University of Texas Medical Branch. Research interests center on: Identifying tumor suppressor genes (e.g., RhoB, TBR3, GATA3) and oncogenes (e.g., FOXO3a, SCD1, NPTX2). Developing patient-derived xenografts and live cell models for personalized medicine. Designing SCD1 inhibitors via in silico modeling for clinical trials. Recent publications highlight his work on SCD1 inhibition in leukemia and thyroid cancer ImmunoPET imaging of thyroid tumors CRISPR-identified drug synergies in cholangiocarcinoma Patient-specific combination therapies using xenograft models

Benjamin Andrew TollView profile

Professor

• Tobacco Cessation
• Smoking Cessation
• Cancer Prevention
• +5 more

Benjamin Andrew Toll is a Professor in the Department of Public Health Sciences and Psychiatry at the Medical University of South Carolina (MUSC) College of Medicine. He serves as Associate Director of Education and Training for the Hollings Cancer Center, Vice Chair of Research in the Department of Public Health Sciences, Co-Director of the Lung Cancer Screening Program, and Director of the Tobacco Treatment Program at MUSC. Dr. Toll received his BA from Cornell University (1996), MS and PhD from Nova Southeastern University (1999, 2002), and completed his Postdoctoral Fellowship and Internship at Yale University. Dr. Toll is a leading researcher in tobacco cessation, with over 20 years of experience conducting clinical trials focused on developing novel therapeutics for tobacco and nicotine use. His work primarily centers on preventing cancer through tobacco treatment interventions, with particular emphasis on lung cancer screening patients and cancer surgery patients. He has expertise in nicotine replacement therapy, contingency management approaches, gain-framed messaging, and digital health interventions for smoking cessation across diverse populations including older adults and young adults. His recent publications demonstrate a strong focus on implementation science for tobacco treatment programs across various healthcare settings including hospitals, oncology clinics, and primary care. His research examines barriers to treatment, optimal delivery methods (including telehealth and EHR-integrated tools), and effectiveness of various pharmacological and behavioral interventions for smoking cessation. National Cancer Institute funding (R01CA235697, R01CA207229, P50CA196530) National Institute on Drug Abuse funding (P50DA036151, K12DA000167) Continuous funding for over 15 years for tobacco cessation research As a mentor and leader, Dr. Toll oversees the Education and Training program at the Hollings Cancer Center, guiding the development of future cancer researchers. His Tobacco Treatment Program serves as a model for integrating tobacco cessation into comprehensive cancer care, and he has successfully implemented 'opt-out' tobacco treatment programs across multiple hospital systems in South Carolina. Dr. Toll leads a multidisciplinary research team focused on tobacco treatment, including psychologists, pharmacists, physicians, and implementation scientists working together to develop and test innovative approaches to smoking cessation for high-risk populations.

Jonathan SantoView profile

Professor

• Developmental Psychology
• Peer Relations
• Child and Adolescent Development
• +3 more

Jonathan Santo is a Professor of Psychology at the University of Nebraska at Omaha (UNO), where he serves as Director of the Graduate Developmental Psychology Program and as a faculty member in the Office of Latino/Latin-American Studies. His research explores peer relations, cultural differences in self-esteem, and classroom-level influences on child and adolescent development, with a focus on improving school environments and fostering positive social interactions. ORCA Faculty Fellow His research spans broad areas including Developmental Psychology , Social Support Systems , and Cross-Cultural Peer Dynamics , with specific attention to peer victimization , self-continuity , school climate , and developmental trajectories in Brazilian and Colombian youth . Recent publications analyze topics like hikikomori experiences , friendship security , and HPA axis dysregulation in adolescents. Scientific awards include the ORCA Faculty Fellow recognition. His work often involves longitudinal assessments of peer relationships cross-cultural comparisons (Brazil, Colombia, China, Nigeria, Singapore, U.S.) policy-focused blog posts on family separations and school interventions

Pourang IraniView profile

Professor

• Human-Computer Interaction
• Information Visualization
• Ubiquitous Computing
• +4 more

Pourang Irani is a Professor and Principal’s Research Chair in Ubiquitous Analytics at the University of British Columbia (Okanagan campus), within the Irving K. Barber Faculty of Science’s Department of Computer Science, Mathematics, Physics and Statistics. Previously, he served at the University of Manitoba for 19 years as a faculty member and Acting Associate Dean of Science. His research focuses on Human-Computer Interaction (HCI), Wearable Computing, and Information Visualization, with an emphasis on designing interactive systems for 'anytime, anywhere' sensemaking using emerging technologies like mixed reality and smart devices. He leads interdisciplinary projects such as the NSERC CREATE grant on Visual and Automated Disease Analytics, training data scientists in health analytics. Education: PhD in Computer Science (University of New Brunswick, 2002), supervised by Dr. Colin Ware. Research Interests: Wearable interfaces (smartwatches, smartrings, and AR/VR) Data visualization for health and pervasive systems Persuasive health technologies and data storytelling Mid-air and hands-free interaction techniques Embodied interaction through social robots Recent Work Trends: Articles emphasize innovations in smartwatch interaction (e.g., bezel-to-bezel gestures), tactile visualizations via skin-dragging, and voice assistant-driven health data queries. Projects like Databiting explore transient personal data exploration, while Data Videos focus on narrative-driven health communication. Grants & Leadership: Principal Investigator of NSERC CREATE Visual and Automated Disease Analytics program. Co-leads UBCO’s Digital Transparency cluster. Active in interdisciplinary teams addressing health informatics and HCI challenges. Labs & Teams: Leads a lab developing prototypes in wearable computing, spatial analytics, and immersive technologies. Collaborates with researchers in medicine, engineering, and data science to translate HCI innovations into practical solutions.

Anita HubleyView profile

Professor

• Adult Development and Aging
• Applied Measurement and Psychometrics (test development & validation)
• Assessment
• +7 more

Anita Hubley is a Professor at the University of British Columbia's Faculty of Education, Department of Educational and Counselling Psychology, and Special Education (ECPS). She serves as MERM Program Coordinator and directs the Adult Development and Psychometrics Lab. Her work focuses on psychometric test development/validation and quality of life research across adult populations. Education: Ph.D. in Psychology (Human Assessment specialization), Carleton University (1995) M.A. in Psychology (Lifespan Development and Aging), University of Victoria (1991) Pre-doctoral training at Geriatric Assessment Unit (Ottawa) and Neuropsychological Assessment Unit (Ottawa) Her research integrates psychometric theory with practical applications in aging populations, homeless/vulnerably housed individuals, and neuropsychological assessment tools. Key contributions include developing the Memory Test for Older Adults (MTOA), Hubley Depression Scale for Older Adults (HDS-OA), Quality of Life in Homeless and Hard-to-House Individuals (QoLHHI), and Subjective Age Identity Scale (SAIS). Scientific Awards: Killam Teaching Prize (2017) Distinguished Reviewer, Buros Institute of Mental Measurements (2013) She has taught graduate courses in Psychological Assessment, Measurement Principles, Scale Development, and Applied Neuropsychology, emphasizing ethical testing practices and response process research. Her lab's work on test adaptation for marginalized populations has informed international measurement standards.